~424 spots leftby Apr 2027

iCHART Intervention for Teen Suicidal Behavior

Recruiting at 4 trial locations
SS
Overseen byStephanie Stepp, PhD
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Pittsburgh
Disqualifiers: Manic, Psychotic, Intellectual disability, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, anhedonia, and stress related to cybervictimization. This study will recruit 900 adolescents which will be enrolled in a randomized controlled trial to test iCHART and will be randomized to iCHART or treatment as usual (TAU). Based on previous work, the investigators hypothesize that iCHART, compared to TAU, will decrease suicidal-related events by 50%, and the effects will be mediated by increases in referrals, treatment engagement, and safety planning. The investigators will use implementation science methods to assess contextual factors (i.e., barriers and facilitators) and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for our predictive algorithm and iCHART to inform future implementation efforts and promote health equity.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the iCHART treatment for teen suicidal behavior?

Research on similar interventions, like the Collaborative Assessment and Management of Suicidality (CAMS) for teens, shows promise in reducing suicidal thoughts and behaviors. These interventions are found to be acceptable and feasible, with preliminary results indicating a significant reduction in suicidal thoughts, suggesting that iCHART could be effective in a similar way.12345

Is the iCHART intervention for teen suicidal behavior safe for humans?

The available research does not provide specific safety data for the iCHART intervention, but similar interventions like the Collaborative Assessment and Management of Suicidality (CAMS) have been found to be acceptable and feasible, suggesting they are generally safe for use in adolescents.12678

How is the iCHART treatment different from other treatments for teen suicidal behavior?

The iCHART treatment is unique because it integrates care specifically designed to help at-risk teens by focusing on understanding the emotional distress and interpersonal issues that contribute to suicidal behavior, and it includes intensive weekly sessions followed by email follow-up, which is not commonly found in standard care.19101112

Research Team

SS

Stephanie Stepp, PhD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for English-speaking teens aged 12-18 with depression or suicidal behavior, and their parents who are over 18 and speak English. Teens must have had recent suicidal thoughts or a history of attempts. Parents need to be biological/adoptive or legal guardians. Teens with severe mental conditions, life-threatening medical issues, intellectual disabilities, or without access to a phone/tablet are excluded.

Inclusion Criteria

Only 1 parent/caregiver will be engaged in research, but in case 1 parent is unavailable, the other may be engaged (meaning it doesn't have to be the same parent participating in assessments/interviews throughout youth study participation).
I (or my caregiver/parent) can speak English.
Parents are considered biological/adoptive parents or have court documentation that they can provide consent for research as a legal guardian of a youth.
See 6 more

Exclusion Criteria

I do not have a severe mental health crisis, life-threatening condition needing immediate care, or a cognitive disability that prevents understanding of the study.
Exclusion criteria include conditions that might impair their ability to effectively deploy ETUDES interventions, including:
There are no specific exclusion criteria for caregivers and providers.
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are enrolled in the iCHART intervention or Treatment As Usual (TAU) to test the effectiveness in reducing suicide-related events

6 months
Regular visits as per primary care provider's schedule

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of suicidal ideation and behavior

12 months

Treatment Details

Interventions

  • iCHART (Behavioral Intervention)
  • Treatment As Usual (Behavioral Intervention)
Trial OverviewThe iCHART intervention aims to reduce suicide-related events in at-risk teens by half compared to usual treatment (TAU). The study will enroll 900 adolescents in a randomized controlled trial comparing iCHART's effectiveness against TAU while assessing factors that affect implementation like acceptability and cost.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: iCHARTExperimental Treatment1 Intervention
iCHART is an intervention that includes 3 components previously studied in within the ETUDES Center including a: 1. Safety Planning App for suicidal youth which enables a primary care provider to streamline the gold standard of care for those with current suicidality symptoms through an app (instead of a paper based version); 2. Mental Health Screener questionnaire that gathers additional mental health symptoms, treatment preferences, and family's readiness for treatment engagement to help primary care provider make a personalized, tailored treatment plan a suicidal youth is more likely to adhere to; 3. Text Messages which aims to provide texts for 2-3 weeks to motivate you to engage with the safety plan and recommended treatment following the patient visit. Participants will receive usual care at their pediatric primary care practice following screening including information, psychoeducation, and referral to a mental health treatment provider.
Group II: Treatment As Usual (TAU)Active Control1 Intervention
Participants in this group will receive usual care from their primary care provider or mental health care provider which may include development of a paper safety plan.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

University of Oregon

Collaborator

Trials
91
Recruited
46,700+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

Kaiser Permanente

Collaborator

Trials
563
Recruited
27,400,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

The CAMS-4Teens intervention was found to be feasible and acceptable for treating adolescents with suicidal thoughts, with high adherence from clinicians during the pilot trial involving 22 participants.
Preliminary results indicated a large effect size in reducing suicidal thoughts among participants, suggesting that CAMS-4Teens may be as effective as established interventions for adolescents.
Collaborative Assessment and Management of Suicidality for Teens: A Promising Frontline Intervention for Addressing Adolescent Suicidality.Adrian, M., Blossom, JB., Chu, PV., et al.[2022]
The study will evaluate a blended intervention combining online cognitive-behavioral therapy (CBT) sessions with face-to-face therapy to reduce suicidal ideation in adolescents, using a cluster randomized controlled trial design in school settings.
Outcomes will be measured at multiple follow-up points (post-intervention, 3, 6, and 12 months) to assess not only suicidal ideation but also related factors like depressive symptoms and emotional regulation, providing comprehensive insights into the intervention's effectiveness.
Testing the Effectiveness of a Blended Intervention to Reduce Suicidal Ideation among School Adolescents in Chile: A Protocol for a Cluster Randomized Controlled Trial.Núñez, D., Gaete, J., Meza, D., et al.[2022]
In a study of 167 adolescents aged 13-18 who attempted suicide, 25.5% did not attend any follow-up care, highlighting a significant gap in post-discharge support for this vulnerable group.
Adolescents who complied with follow-up care tended to have more severe mental health issues, such as higher levels of depression and anxiety, suggesting that those in greater need of support may be less likely to seek it, but scheduling follow-up appointments before discharge improved compliance.
Predictive factors of post-discharge follow-up care among adolescent suicide attempters.Granboulan, V., Roudot-Thoraval, F., Lemerle, S., et al.[2019]

References

Collaborative Assessment and Management of Suicidality for Teens: A Promising Frontline Intervention for Addressing Adolescent Suicidality. [2022]
Testing the Effectiveness of a Blended Intervention to Reduce Suicidal Ideation among School Adolescents in Chile: A Protocol for a Cluster Randomized Controlled Trial. [2022]
Predictive factors of post-discharge follow-up care among adolescent suicide attempters. [2019]
Improving care for depression and suicide risk in adolescents: innovative strategies for bringing treatments to community settings. [2023]
Successful Treatment of Suicidal Risk. [2022]
A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality versus Enhanced Care as Usual With Suicidal Soldiers. [2019]
Safety plan use in the daily lives of adolescents after psychiatric hospitalization. [2023]
Health Care Resources and Mental Health Service Use Among Suicidal Adolescents. [2022]
Ultra-brief crisis interpersonal psychotherapy based intervention for suicidal children and adolescents. [2021]
The aftercare of adolescents with deliberate self-harm. [2022]
Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR). [2021]
12.Korea (South)pubmed.ncbi.nlm.nih.gov
[The development of an integrated suicide-violence prevention program for adolescents]. [2022]